| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Adenocarcinoma (non-small cell lung cancer) | 105 | 2 | |
| Non-small cell lung cancer | 60 | 0 | |
| Lung cancer | 42 | 0 | |
| Squamous cell carcinoma (non-small cell lung cancer) | 28 | 0 | |
| Adenosquamous carcinoma (non-small cell lung cancer) | 14 | 0 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Shortness of breath with exertion | 3 | |
| Chest pain | 1 | |
| Low blood oxygen levels (hypoxemia) | 1 | |
| Muscle soreness | 1 | |
| Nerve pain (neuralgia) | 1 | |
| Numbness | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 2 | |
| Mild | 1 | |
| None | 0 |